TABLE 3.
Results of the laboratory investigation of skin samplesa
Patient code | Sample | Result of: |
GenoType LepraeDR result |
|||||
---|---|---|---|---|---|---|---|---|
Ziehl-Neelsen microscopy (BI) | Fluorescent microscopy | PCR for rpoB | Detection of M. leprae | Rifampin resistance | Dapsone resistance | Ofloxacin resistance | ||
P1 | Skin biopsy | Neg | Neg | Neg | NA | NA | NA | NA |
P2 | Skin biopsy | Pos (4+) | Pos | ML | ML | Sensitive | Sensitive | Sensitive |
P3 | Skin biopsy | Neg | Neg | Neg | NA | NA | NA | NA |
P4 | Skin biopsy | Pos (3+) | Pos | ML | ML | Sensitive | Sensitive | Sensitive |
P5 | Skin biopsy | Pos (1+) | Pos | Neg | Neg | NA | NA | NA |
P6 | Skin biopsy | Neg | Neg | Neg | NA | NA | NA | NA |
P7 | Skin biopsy | Neg | Neg | Neg | NA | NA | NA | NA |
P8 | Skin biopsy | Neg | Neg | Neg | NA | NA | NA | NA |
P9 | Skin biopsy | Neg | Neg | Neg | NA | NA | NA | NA |
P10 | Skin biopsy | Neg | Neg | Neg | NA | NA | NA | NA |
P11 | Skin biopsy | Neg | Neg | Neg | NA | NA | NA | NA |
P12 | Skin biopsy | Neg | Neg | Neg | NA | NA | NA | NA |
P13 | Skin biopsy | Neg | Neg | Neg | NA | NA | NA | NA |
P14 | Skin biopsy | Neg | Neg | Neg | NA | NA | NA | NA |
P15 | Slit skin | Neg | Neg | Neg | NA | NA | NA | NA |
P16 | Slit skin | Neg | Neg | Neg | NA | NA | NA | NA |
P17 | Slit skin | Neg | Neg | Neg | NA | NA | NA | NA |
P18 | Slit skin | Neg | Neg | Neg | NA | NA | NA | NA |
P19 | Slit skin | Neg | Neg | Neg | NA | NA | NA | NA |
P20 | Slit skin | Neg | Neg | Neg | NA | NA | NA | NA |
P21 | Skin biopsy | Pos (5+) | Pos | ML | NT | NT | NT | NT |
Skin swab (3) | Pos (3+) | Pos | ML | NT | NT | NT | NT | |
P22 | Swab of ulcerative skin | Neg | Neg | Neg | NA | NA | NA | NA |
P23 | Swab of ulcerative skin | Neg | Neg | Neg | NA | NA | NA | NA |
P24 | Skin biopsy | Neg | Neg | Neg | NA | NA | NA | NA |
8111270308* | Skin biopsy | Neg | Neg | Neg | NA | NA | NA | NA |
8121367852* | Skin biopsy | Neg | Neg | Neg | NA | NA | NA | NA |
9011404509* | Skin biopsy | Neg | Neg | Neg | NA | NA | NA | NA |
NA, not applicable; Neg, negative; Pos, positive; *, negative-control sample collected from patient admitted to the Institut Hospitalier Universitaire Méditerranée Infection, Marseille, France, and presenting skin lesions devoid of any evidence of mycobacteria; NT, not tested; 3, three swabs collected from three types of skin lesions (skin wound, scaly skin evoking cutaneous leishmaniasis, and skin papules with raised extremities) in patient P21; BI, bacterial index determined using Ridley’s logarithmic scale (22).